sheila kaplanapril washington food drug administration monday said would require bayer restrict sales essure birth control implant medical practices like doctors offices agree fully inform women device risks since implant became available years ago thousands women sued bayer essure manufacturer many claiming suffered severe injuries including perforation uterus fallopian tubes metal implant two years ago f declined pull device market instead ordered placement black box warning product package said could cause types injuries warning also noted implant travel abdomen pelvic cavity causing pain possibly requiring surgical removal consisting two small coils made nickel alloy polyester like fiber device placed fallopian tubes vagina designed create inflammatory response causes scar tissue form block tubes f said monday nov essure approved december last year agency received reports adverse events related device although might duplicates frequently reported problems f said pain menstrual irregularities headache reports listed multiple conditions suffered individual patients also reports deaths pregnancy loss ectopic pregnancies serious problems steven immergut spokesman bayer said roughly devices sold worldwide experienced decline sales due broad dissemination misleading inaccurate information social media influencing women choices said dr scott gottlieb f commissioner met february group women concerned continuing injuries connected device demanded device withdrawn market others sought stronger warning please verify youre robot clicking box invalid email address please enter must select newsletter subscribe view new york times newsletters one large concerns women got essure idea warning device doctor patient discussion checklist said holly ennis lawyer represents hundreds women suing bayer device action announced monday require doctors ensure patients sign form checklist acknowledging advised implants risks also require doctor signature bayer released statement monday saying issued new label birth control device emphasizing health care providers must discuss risks patients benefit risk profile essure changed remains positive company said version article appears print april page new york edition headline f restrict sales birth control implant order reprints todays paper subscribe interested feedback page tell us think go home page